Bioverativ Inc. (BIVV) Tops Q2 EPS by 17c
Get Alerts BIVV Hot Sheet
Join SI Premium – FREE
Bioverativ Inc. (NASDAQ: BIVV) reported Q2 EPS of $0.88, $0.17 better than the analyst estimate of $0.71. Revenue for the quarter came in at $289.1 million versus the consensus estimate of $268 million.
For earnings history and earnings-related data on Bioverativ Inc. (BIVV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- Koil Energy Solutions, Inc. (KLNG) Reports Q4 Loss of $0.07
- urban-gro Inc. (UGRO) Misses Q4 EPS by 22c, offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!